Regulation & Compliance

A novel inhaled RNA therapy for a specific group of cystic fibrosis patients gains EMA fast-track status, promising accelerated access to new treatment.

With over 100% revenue growth, Ada's success highlights a major industry shift from AI experiments to fully integrated agentic customer experience models.

A major renewal with a 30M-client bank highlights the industry's shift to biometrics, boosting BIO-key's finances and solidifying its market niche.

At QuanCon 2026, Quantexa unveiled a landmark partnership with Moody’s, positioning Decision Intelligence as the core of next-gen AI organizations.

K2 International launches a professional indemnity unit led by 40-year veteran Richard Smart, targeting the global market from London with Lloyd's backing.

Chicago attorney Eirene N. Salvi's Crain's honor highlights a career balancing record-setting verdicts with profound community service and judicial reform.

The trans-pacific merger between US BioTek and Australia's NutriPATH creates a major new force in functional medicine, promising expanded global access.

Little Rapids Corporation merges its paper and packaging arms into Rapids Paper + Packaging, a new entity aimed at tackling plastic waste with integrated solutions.

Publishing giant convenes leaders to define standards for adaptive knowledge, tackling IP, trust, and the very future of reading in the age of AI.

A federal policy loophole is diverting billions from struggling rural providers to wealthy urban hospitals, threatening care for millions of Americans.

New data reveals Vermont's long-term care costs are among the nation's highest, forcing families and policymakers to confront a growing financial crisis.

Great Hill Partners appoints AI head Leland Lockhart, signaling a critical trend where specialized tech leadership becomes the new frontier for value creation.

A new national agreement gives thousands of U.S. hospitals streamlined access to Nanosonics' trophon3, aiming to elevate patient safety standards.

A new study aims to confirm a novel immunotherapy's dramatic results in colorectal cancer, offering hope for patients with limited treatment options.

Forum Investment Group hires Ares vet Grant Turner in a strategic bid to scale its 1031 exchange platform and capture the booming tax-advantaged market.

Halia Therapeutics is betting on a novel target to fight chronic inflammation. At a key summit, it will pitch its unique approach for cancer, obesity, and Alzheimer's.

Snack giant Our Home unveils a strategic pivot at Expo West, doubling down on protein and avocado oil to capture the modern, health-conscious consumer.

Monjur's new AI platform, supervised by attorneys, promises to speed up deals and cut legal risks for Managed Service Providers.

After a major turnaround, Genetix Biotherapeutics announces its first profitable quarter and plans to double production of its high-stakes gene therapies.

French giant Efor deepens its North American footprint, acquiring CQV specialist DynamixE to target the complex cell and gene therapy manufacturing market.